Privia Health Group, Inc. (PRVA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PRVA currently has 124M outstanding shares. with moderate dilution risk from 25.5M authorized shares representing 20.5% potential dilution. The company has minimally diluted shareholders by 4.22% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 124.2M shares outstanding |
120M | 26M |
| Nov 06, 2025 |
10-Q filing | 122.8M shares outstanding |
120M | 26M |
| Aug 07, 2025 |
10-Q filing | 122.1M shares outstanding |
120M | 26M |
| May 08, 2025 |
10-Q filing | 120.6M shares outstanding |
120M | 26M |
| Feb 27, 2025 |
10-K filing | 119.4M shares outstanding |
120M | 26M |
| Nov 07, 2024 |
10-Q filing | 119.7M shares outstanding |
120M | 26M |
| Aug 08, 2024 |
10-Q filing | 119.3M shares outstanding |
120M | 26M |
| May 09, 2024 |
10-Q filing | 118.5M shares outstanding |
120M | 26M |
| Feb 27, 2024 |
10-K filing | 116.7M shares outstanding |
120M | 26M |
| Nov 03, 2023 |
10-Q filing | 117.6M shares outstanding |
120M | 26M |
| Aug 03, 2023 |
10-Q filing | 116.2M shares outstanding |
120M | 26M |
| May 04, 2023 |
10-Q filing | 115.0M shares outstanding |
120M | 26M |
| Mar 07, 2023 |
8-K filing: Privia Health Group, Inc. entered into an Equity Alignment Agreement with ChoiceHealth, Inc., a subsidiary of Novant Health, Inc., to issue shares of the Company's common stock to Novant Sub based on certain milestones related to provider implementation and new state partnerships, subject to a cap of 19.9% of the outstanding common stock. |
110M | 26M |
| Mar 01, 2023 |
10-K filing | 110.7M shares outstanding |
110M | 26M |
| Nov 21, 2022 |
8-K filing: Privia Health Group, Inc. completed an underwritten offering of 5,000,000 shares of its common stock by selling stockholders, with underwriters exercising their option to purchase an additional 750,000 shares. The offering closed on November 21, 2022, and the company did not receive any proceeds from the sale. |
110M | 26M |
| Nov 10, 2022 |
10-Q filing | 111.6M shares outstanding |
110M | 26M |
| Aug 11, 2022 |
10-Q filing | 108.7M shares outstanding |
110M | 26M |
| May 12, 2022 |
10-Q filing | 108.1M shares outstanding |
110M | 26M |
| Mar 25, 2022 |
10-K filing | 103.0M shares outstanding |
100M | 26M |
| Nov 16, 2021 |
S-1 filing: Privia Health Group, Inc. is offering 6,000,000 shares of common stock by selling shareholders, with the last reported sales price of the common stock being $29.76 per share on November 15, 2021. |
210M | 26M |
| Nov 08, 2021 |
10-Q filing | 105.9M shares outstanding |
110M | 20M |
| Aug 09, 2021 |
10-Q filing | 102.7M shares outstanding |
100M | 20M |
| May 28, 2021 |
10-Q filing | 96.0M shares outstanding |
96M | 20M |
| Apr 28, 2021 |
S-1/A filing: Privia Health Group, Inc. is offering 2,800,000 shares of its common stock and the selling shareholder is selling 16,700,000 shares of Privia Health common stock in its initial public offering. |
N/A | 20M |
| Apr 22, 2021 |
S-1/A filing: Privia Health Group, Inc. is offering 2,800,000 shares of its common stock and the selling shareholder is selling 16,700,000 shares of Privia Health common stock in an initial public offering. |
N/A | 20M |
| Apr 22, 2021 |
S-1/A filing: Privia Health Group, Inc. is offering 2,800,000 shares of its common stock and the selling shareholder is selling 16,700,000 shares of Privia Health ’s common stock in its initial public offering. |
N/A | 20M |